Subscribe to Finance

The Lead

Fed Grant for Pain-Free Blood Test Startup at UW

April 17, 2015 12:32 pm | by University of Wisconsin - Madison | News | Comments

A company with deep roots at the University of Wisconsin-Madison wants to make blood sampling less painful and more convenient.

Innocrin Raises $28 Million in Series D Financing

April 15, 2015 11:10 am | by Innocrin Pharmaceuticals | News | Comments

Innocrin Pharmaceuticals is developing small-molecule CYP17 lyase-selective inhibitors to treat...

Recipharm Equity Investment in Synthonics

April 14, 2015 11:43 am | by Recipharm | News | Comments

$2.0 million of preferred stock will be purchased upon Synthonics’ achievement of certain...

Top Mid-Cap Biotech Companies Increased Revenues to $26.5 Billion in 2014

April 9, 2015 2:10 pm | by GlobalData | News | Comments

GlobalData’s Healthcare Industry Analyst says the rise in biotech peer group total revenue over...

View Sample

FREE Email Newsletter

World Health Day: Budget Cuts, Vaccine Fears Threaten Health Progress

April 7, 2015 1:11 pm | by Alice Hazelton, SciDev.Net | News | Comments

Cuts to global health research budgets and people’s wariness of vaccines could hamper efforts to improve health around the world.

Shares of Arena Rise Due to Weight Loss Drug Patent

April 7, 2015 12:42 pm | by The Associated Press | News | Comments

Shares of Arena Pharmaceuticals rose Tuesday after the drug developer said it received an additional patent for its weight loss drug Belviq.

Arvinas Strategic R&D Collaboration with Merck

April 7, 2015 12:36 pm | by Arvinas | News | Comments

Arvinas announced a strategic collaboration with Merck with the goal of creating novel therapeutics based on protein degradation.


Nektar Recieves $100M Milestone from AstraZeneca

April 6, 2015 12:16 pm | by Nektar Therapeutics | News | Comments

The cash payment under the Nektar-AstraZeneca agreement was triggered by the first commercial sale of MOVANTIK (naloxegol) in the U.S. 

Indiegogo Campaign to Develop Medical Cannabis in Ireland

April 2, 2015 1:28 pm | by GreenLight Health | News | Comments

An Irish healthcare company has launched a crowdfunding campaign on Indiegogo to raise funds to research and develop affordable medical cannabis.

Cellceutix Enters $30 Million Common Stock Purchase Agreement

April 2, 2015 1:19 pm | by Cellceutix Corporation | News | Comments

Cellceutix Corporation, a clinical stage biopharmaceutical company, has signed a $30 million stock purchase agreement with Aspire Capital Fund, LLC.

RA Treatment Market Value to Reach $9.3 Billion by 2020

April 1, 2015 1:08 pm | by GBI Research | News | Comments

The U.S. treatment market for Rheumatoid Arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020.

Analyst: Biotech M & A 'Arms Race'

April 1, 2015 12:50 pm | by Goldman Small Cap Research | News | Comments

Analyst Rob Goldman says mid-stage biotech companies are being built for potential sale, in an environment of increasing mergers and acquisitions.


Potential Billion-Dollar Verdict Rests on Disputed Deadline

March 27, 2015 8:00 am | by ADAM BEAM, Associated Press | News | Comments

What does it cost to miss a deadline? For the company that makes the prescription painkiller Oxycontin, the answer could be more than $1 billion.

Dow Chemical, Olin in $5B Cash-and-Stock Deal

March 27, 2015 7:53 am | News | Comments

Dow Chemical is breaking off a significant portion of its chlorine operations in a deal valued at $5 billion.

Report: Sepsis Treatment Market to Dramatically Expand Following 2016 Drug Debut

March 26, 2015 3:33 pm | by Andy Szal, Digital Reporter | News | Comments

A new report expects the market value for sepsis treatments to increase more than thirteen-fold between 2016 and 2021 following the launch of a new sepsis-specific drug.

Genentech Announces Plans to Expand Hillsboro Facility

March 26, 2015 3:26 pm | News | Comments

Genentech, a member of the Roche Group, has announced plans to invest more than $125 million for the expansion of its fill/finish facility in Hillsboro, Oregon.

Capsugel Investing More Than $25M in Increased Production Capacity and Quality Enhancements

March 26, 2015 7:59 am | News | Comments

Capsugel has announced that the company is investing more than $25 million to increase production capacity and deliver further quality enhancements for its vegetarian capsules.


Justices to Hear Arguments Over EPA Mercury Limits

March 25, 2015 8:18 am | by MARK SHERMAN, Associated Press | News | Comments

The Supreme Court is taking up a challenge by industry groups and Republican-led states that want to roll back Obama administration environmental rules aimed at reducing power plant emissions of mercury and other hazardous air pollutants that contribute to respiratory illnesses, birth defects and developmental problems in children.

Merck Board OKs Additional $10B Stock Buyback Plan

March 25, 2015 8:15 am | News | Comments

Merck & Co. says its board approved the repurchase of up to $10 billion more of its stock. The company said that amount will be added to the $1.7B remaining available for repurchase under a prior authorization.

Sun Pharma Announces Closure of Merger Deal with Ranbaxy

March 25, 2015 8:11 am | News | Comments

Sun Pharma today, begins the integration of Ranbaxy's business following the successful closure of its merger.  The integration, planned by Sun Pharma over many months, will focus on supporting strong growth.

Lycera Announces Milestone in Merck Collaboration

March 25, 2015 8:04 am | News | Comments

Lycera Corp. today announced the achievement of a milestone under the Company's collaboration agreement with Merck, known as MSD outside the United States and Canada, triggering an undisclosed payment.

GOP Hits Medicaid to Offset Doctor Fee Hikes

March 24, 2015 8:35 am | by DAVID ESPO, AP Special Correspondent | News | Comments

House Republicans quietly deepened recommended budget savings from the government's chief health care program for the poor by about $140 billion in recent weeks to offset part of the cost of higher payments to doctors who treat Medicare patients, according to officials familiar with the tradeoff.

BMS Acquires Exclusive License from Novo Nordisk for a Discovery Research Program Focused on Autoimmune Diseases

March 24, 2015 8:16 am | News | Comments

Bristol-Myers Squibb Company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research program focused on modulating the innate immune system as a therapy for autoimmune diseases.

WHO Denies Politics Swayed Ebola Emergency Declaration

March 23, 2015 4:14 pm | by MARIA CHENG, Associated Press; RAPHAEL SATTER, Associated Press | News | Comments

The World Health Organization denied that politics swayed the decision to declare an international emergency over the spread of the Ebola virus last year, despite evidence senior staffers repeatedly discussed the diplomatic and economic fallout of such a move.

ImmunoGen Lands Licensing Deal with Takeda

March 23, 2015 4:08 pm | by The Associated Press | News | Comments

Takeda will use ImmunoGen's technology to develop cancer treatments. ImmunoGen will get $20 million upfront and is eligible for milestone payments potentially totaling up to $210 million, plus royalties on sales.

Report Finds Pharmaceutical Industry Increased Its Impact on Global Economy

March 23, 2015 8:30 am | by Andy Szal, Digital Reporter | News | Comments

A recent report found the pharmaceutical industry increased its contribution to the global economy between 2006 and 2012.

Academic Research Added More than $1 Trillion to U.S. Economy

March 23, 2015 8:25 am | by Andy Szal, Digital Reporter | News | Comments

Over nearly two decades, inventions and products licensed by academic institutions contributed more than $1 trillion to the U.S. economy, according to a recent report from the Biotechnology Industry Organization.

Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab

March 23, 2015 8:07 am | News | Comments

Pfizer and Eli Lilly announced today that they are preparing to resume the Phase 3 clinical program for tanezumab. As a result, Pfizer expects to receive a $200 million upfront payment from Lilly in accordance with their collaboration agreement.

Evotec and Sanofi Sign Agreement for Major Multi-Component Strategic Alliance

March 20, 2015 8:05 am | News | Comments

Evotec AG today announced that a definitive agreement for a major multi-component strategic alliance over the next five years has been signed with Sanofi. The transaction is expected to close on 31 March 2015.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.